Concord Biotech Limited IPO Detail
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.
The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.
Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Company Promoters
IPO Details
| IPO Opening Date | Aug 04, 2023 |
| IPO Closing Date | Aug 08, 2023 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹1 per equity share |
| IPO Price | ₹705 - 741 per equity share |
| Market Lot | 20 Shares |
| Min Order Quantity | 20 Shares |
| Listing At | BSE, NSE |
| Issue Size | ₹1,551.00 Cr |
| Fresh Issue | - |
| Offer for Sale | ₹1,551.00 Cr |
| Retail Portion | 35% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | 0.00x | - | - | 0.00x | 0.00x | 0.00x |
| Day 2 | 0.00x | - | - | 0.00x | 0.00x | 0.00x |
| Day 3 | 0.01x | - | - | 1.01x | 0.72x | 0.58x |
| Day 4 | 1.61x | - | - | 5.22x | 2.27x | 2.72x |
| Day 5 | 67.67x | - | - | 16.99x | 3.78x | 24.86x |
IPO Tentative Timetable
The Concord Biotech Limited IPO open date is Aug 04, 2023, and the close date is Aug 08, 2023. The issue may list on Aug 18, 2023.
| IPO Open Date | Aug 04, 2023 |
| IPO Close Date | Aug 08, 2023 |
| Basis of Allotment Date | Aug 11, 2023 |
| Initiation of Refunds | Aug 14, 2023 |
| Credit of Shares to Demat Account | Aug 17, 2023 |
| IPO Listing Date | Aug 18, 2023 |
IPO Lot Size
The Concord Biotech Limited IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹192660).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 20 | ₹14820 |
| Maximum | 13 | 260 | ₹192660 |
IPO Promoter Holding
| Pre Issue Share Holding | 44.08% |
| Post Issue Share Holding | 44.08% |
Company Financials:
For the year/period ended (₹ in Cr.)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 1182.55 | 630.75 | 234.89 |
| 31-Mar-22 | 1312.80 | 736.35 | 174.93 |
| 31-Mar-23 | 1513.98 | 888.48 | 240.08 |
Objects of the Issue:
The objectives of the Offer are to:
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
- Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.
Concord Biotech Limited IPO Registrar:
Link Intime India Private Ltd
Concord Biotech Limited IPO Lead Manager(s):
Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited
Company Contact Information:
Concord Biotech Limited
1482-86,
Trasad Road Dholka,
Ahmedabad – 382225
